Dr.
Courtney Aldrich seminar was on antibiotic design, specifically about those
that target Biotin metabolism which is utilized by Mycobacterium tuberculosis, the organisms responsible for the
disease, tuberculosis. According to Dr. Aldrich, new antibiotics will be
developed through the use of the unbiased phenotypic whole-cell screening
technique in which compounds with antibiotic activity are obtained and of
those, the ones that are multi-target inhibitors are identified.
According to Wanisa Salaemae, Al Azhar, Grant W. Booker,
Steven W. Polyak, School of Molecular and Biomedical Sciences, University of
Adelaide, South Australia 5005, Australia, Biotin is an important micronutrient
that serves as an essential enzyme cofactor. Bacteria obtain biotin either through
de novo synthesis or by active uptake from exogenous sources. Mycobacteria are
unusual amongst bacteria in that their primary source of biotin is through de
novo synthesis.
Tuberculosis has been
classified as a “modern emerging infectious disease” because though we are very
familiar with the standard and older forms of the disease, we are much less
familiar with the newer, drug resistant and fungal forms of the disease. Dr. Aldrich was able to describe the ways antibiotics are designed and created. These are in two ways; biased based target where researchers focus on specific enzymes' pathway or phenotype whole cell screening which would be the method which the majority of future antibiotics would be discovered...
The complex
life cycle of mycobacterium tuberculosis, the pathogenic bacilli responsible
for TB, also contributes to the bacteria’s extraordinary ability to evade
antibiotic therapy (Russell et al., 2010). Most antibiotics are effective
against actively growing Mycobacterium as they target metabolic processes
required for the primary progressive stage of infection (Baek et al., 2011;
Koulet al., 2011).
Dr. Aldrich concluded that the
new biotin-targeted drugs development can be effective as a product of biased-target
based rationale and that it is very important to recognize the drug’s use in
vivo in the body-for the drugs he has been working to synthesize as well as all
other drugs.
No comments:
Post a Comment